{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:17:27Z","timestamp":1792653447889,"version":"4.5.0"},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["aao-hnsfjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngol.--head neck surg."],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>The purpose of this study was to explore the mechanism and utility of everolimus as a single\u2010agent therapy in preventing mouse laryngeal allograft rejection.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN<\/jats:title><jats:p>Prospective animal study.<\/jats:p><\/jats:sec><jats:sec><jats:title>SETTING<\/jats:title><jats:p>Academic research at a tertiary medical center.<\/jats:p><\/jats:sec><jats:sec><jats:title>SUBJECTS AND METHODS<\/jats:title><jats:p>Fifteen recipient mice (five per group) were injected with everolimus (1\u00a0mg\/kg\/d) until euthanized at 15, 30, and 60\u00a0days posttransplantation. Five mice received transplants without immunosuppression and were euthanized at day 15. Larynges were graded for rejection severity. Draining lymph nodes and spleens were evaluated by flow cytometry to assess the systemic immunological environment.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Each time group demonstrated minor allograft rejection (rejection severity scores: 2.51, 2.46, 2.78; no rejection, 1; severe, 6). This was not significantly different between groups. Everolimus\u2010treated mice had significantly less rejection at all time points compared with non\u2010immunosuppressed mice. Flow cytometry showed a blunted cytotoxic T\u2010cell response, differentiation favoring regulatory T\u2010cells, and decreased number and function of dendritic cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Everolimus successfully prevents laryngeal allograft rejection up to 60\u00a0days posttransplantation. It appears to increase the production of regulatory T\u2010cells while decreasing cytotoxic T\u2010cell and dendritic cell response. Everolimus alone or in combination with other immunosuppressants may enable laryngeal transplantation to become a viable reconstructive option following laryngectomy for malignancy.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.otohns.2009.10.019","type":"journal-article","created":{"date-parts":[[2009,12,25]],"date-time":"2009-12-25T04:11:07Z","timestamp":1261714267000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long\u2010Term Laryngeal Allograft Survival Using Low\u2010Dose Everolimus"],"prefix":"10.1002","volume":"142","author":[{"given":"David G.","family":"Lott","sequence":"first","affiliation":[{"name":"Cleveland Clinic Head and Neck Institute New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Dan","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Head and Neck Institute New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Lu","sequence":"additional","affiliation":[{"name":"Cleveland Clinic Surgery Institute Department of Immunology New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Strome","sequence":"additional","affiliation":[{"name":"New York Head and Neck Institute New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,1]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"163","article-title":"Laryngeal and tracheal transplantation: ethical limitations","volume":"70","author":"Genden EM","year":"2003","journal-title":"Mt Sinai J Med"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105313442204"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1998.tb00832.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.2106\/00004623-200210000-00020"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90245-1"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2001.24645"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199707150-00008"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.483"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2770"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2006.08.016"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlg.0000210544.64659.35"},{"key":"e_1_2_7_13_1","unstructured":"Dana Farber Cancer Institute.Cisplatin and everolimus in treating patients with advanced solid tumors or recurrent or metastatic head and neck cancer. Available at:http:\/\/www.dana\u2010farber.org\/can\/clinical\/View.aspx?doc=CDR0000525762&audience=0. Accessed January 1 2009."},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940611500111"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLG.0b013e3181855108"},{"key":"e_1_2_7_16_1","unstructured":"LottDG ShipchandlerTZ DanO et al.A new mouse laryngeal transplantation rejection grading system.Laryngoscope.2009Oct 29 [Epub ahead of print]."},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348940911800610"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.11.6178"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.944"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-3274(03)00050-9"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.7.3555"}],"container-title":["Otolaryngology\u2013Head and Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.otohns.2009.10.019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1016\/j.otohns.2009.10.019","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aao-hnsfjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.otohns.2009.10.019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:41:12Z","timestamp":1760956872000},"score":1,"resource":{"primary":{"URL":"https:\/\/aao-hnsfjournals.onlinelibrary.wiley.com\/doi\/10.1016\/j.otohns.2009.10.019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1016\/j.otohns.2009.10.019"],"URL":"https:\/\/doi.org\/10.1016\/j.otohns.2009.10.019","archive":["Portico"],"relation":{},"ISSN":["0194-5998","1097-6817"],"issn-type":[{"value":"0194-5998","type":"print"},{"value":"1097-6817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"2009-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-03-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2010-01-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}